Results 131 to 140 of about 7,361 (190)

Cardiovascular safety of 5α-reductase inhibitors in people with benign prostatic hyperplasia and type 2 diabetes: a propensity score-matched analysis. [PDF]

Eur Heart J Cardiovasc Pharmacother
Tu H, Ju C, McGurnaghan SJ, Blackbourn LAK, Scottish Diabetes Research Network Epidemiology Group, Pearson E, Wei L, Andrew R.   +7 more
europepmc   +1 more source

Dispensing practices issue shorter prescription lengths compared with non-dispensing practices: a quasi-experimental cross-sectional study. [PDF]

BJGP Open
Holdroyd I, Loftus L, Appel C, Massou E, Ford J.   +4 more
europepmc   +1 more source

Editorial: Advances in neuromodulation for chronic pain: mechanisms and clinical implications. [PDF]

Front Pain Res (Lausanne)
Jiang H, Sun L, Liu F, Jiang H.
europepmc   +1 more source

Ningmitai capsule in patients with chronic prostatitis/chronic pelvic pain syndrome: a multicenter, prospective, randomized, parallel, positive-controlled study. [PDF]

Front Pharmacol
Gao J, Zhang Y, Du J, Liu Q, Cheng Y, Yang W, Wang D, Wang W, Zheng L, Wang D, Wu L, Jiang X, Men Q, Liang C, Zhang X.   +14 more
europepmc   +1 more source

Evidence for the Additional Health Benefits Associated with Phosphodiesterase 5 Inhibitors when Used for Treating Erectile Dysfunction, with a Focus on Prostate Cancer Patients and Other Associated Conditions. [PDF]

World J Mens Health
Naranjo A, Hackett GI, Smith S, Stephens H, Kinnaird W, Kirby M.   +5 more
europepmc   +1 more source

Bilateral Prostate Artery Embolization for Massive Benign Prostatic Hyperplasia in a Frail Elderly Patient With Recurrent Urinary Retention. [PDF]

Cureus
Cuni Hernandez AB, Carruthers P, Blanco Espinosa E, Cruzata Matos I, Garcia Gonzalez CA, Diaz Perez L, Garces Ruiz R.   +6 more
europepmc   +1 more source

Do Alpha-Blockers and 5-Alpha Reductase Inhibitors Increase Dementia Risk? A Network Meta-analysis. [PDF]

Int Neurourol J
Niaga KJK, Rinaldi FX, Nathania N, Supinto PA, Lionardi SK, Yo R, Wilyono A, Silalahi PY.   +7 more
europepmc   +1 more source

Off-label prescribing of tamsulosin: A nationwide retrospective study combining prescription and regulatory data. [PDF]

Explor Res Clin Soc Pharm
Artner A, Niedermüller Á, Csapó MA, Hanh NN, Fekete E, Zelkó R, Sebők S.   +6 more
europepmc   +1 more source

Postoperative Urinary Retention After Hernia Repair: A Randomized Controlled Trial Identifying Patients at Risk and Assessing the Incidence After Tamsulosin Pretreatment. [PDF]

HCA Healthc J Med
Epps BM, Coile E, Carey M, Whipple O, Kelly R, Senkowski C, Garber J.   +6 more
europepmc   +1 more source

A systematic review and meta-analysis of the efficacy and safety of mirabegron vs. tamsulosin in alleviating double-J catheter related symptoms. [PDF]

Front Med (Lausanne)
Zhang J, Wang D, Chi J, Lou K, Wu J, Cui Y.   +5 more
europepmc   +1 more source